Bruton's tyrosine kinase (BTK) inhibitors
- Name
- Bruton's tyrosine kinase (BTK) inhibitors
- Accession Number
- DBCAT005749
- Description
Not Available
- ATC Classification
- Drugs
Drug Drug Description Ibrutinib An antineoplastic agent used to treat chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenstrom's Macroglobulinemia. Acalabrutinib A Bruton tyrosine kinase inhibitor used to treat mantle cell lymphoma, chronic lymphocytic leukemia, and small lymphocytic lymphoma. Zanubrutinib A kinase inhibitor used to treat mantle cell lymphoma, a type of B-cell non-Hodgkin lymphoma, in adults who previously received therapy. Pirtobrutinib A kinase inhibitor used to treat relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy. - Drugs & Drug Targets